Artificial Intelligence for Generating Drug-like Molecules: A Taxonomy of Methods and Evaluation Strategies

Generative artificial intelligence (AI) is increasingly used for de novo small-molecule design, but the practical and translational utility of generated candidates depends on the configuration of the entire discovery workflow rather than on generative model architecture alone. This review adopts a workflow-based perspective on generative molecular design, tracing the process from existing molecular data sets, preprocessing and representation, to molecule generation, conditioning, candidate prioritization, evaluation, and iterative refinement. It examines how generative AI model families, constraints, and predictive oracles interact within this pipeline, and evaluates generated candidates using intrinsic metrics, computational assessments, and experimental and translational evidence. Active learning, computational and experimental feedback, and human expert input are further discussed as mechanisms for closed-loop refinement. Across these stages, we identify data construction and representation choices, oracle quality, evaluation protocols, and the availability of informative feedback as major determinants of how model performance should be interpreted and whether generated structures progress toward biologically and translationally meaningful candidates, with selected examples. In conclusion, reliable generative drug discovery requires coordinated design across the entire workflow rather than isolated advances in individual components.

Authors

Institutions

Publication Details

Journal
Journal of Chemical Information and Modeling
Published
2026-11-18
DOI
https://doi.org/10.1021/acs.jcim.6c02793
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Artificial Intelligence for Generating Drug-like Molecules: A Taxonomy of Methods and Evaluation Strategies

Gilbert S. Omenn, Emily M. Wittrup, Kayvan Najarian, Chia-Chu Fan et al.
Journal of Chemical Information and Modeling
Computational Drug Discovery Methods
article

Artificial Intelligence for Generating Drug-like Molecules: A Taxonomy of Methods and Evaluation Strategies

Gilbert S. Omenn, Emily M. Wittrup, Kayvan Najarian, Chia-Chu Fan, Morgen Henry
article en

Abstract

Generative artificial intelligence (AI) is increasingly used for de novo small-molecule design, but the practical and translational utility of generated candidates depends on the configuration of the entire discovery workflow rather than on generative model architecture alone. This review adopts a workflow-based perspective on generative molecular design, tracing the process from existing molecular data sets, preprocessing and representation, to molecule generation, conditioning, candidate prioritization, evaluation, and iterative refinement. It examines how generative AI model families, constraints, and predictive oracles interact within this pipeline, and evaluates generated candidates using intrinsic metrics, computational assessments, and experimental and translational evidence. Active learning, computational and experimental feedback, and human expert input are further discussed as mechanisms for closed-loop refinement. Across these stages, we identify data construction and representation choices, oracle quality, evaluation protocols, and the availability of informative feedback as major determinants of how model performance should be interpreted and whether generated structures progress toward biologically and translationally meaningful candidates, with selected examples. In conclusion, reliable generative drug discovery requires coordinated design across the entire workflow rather than isolated advances in individual components.

Journal of Chemical Information and Modeling
University of Michigan (US)
Institute for Healthcare Policy and Innovation, University of Michigan, National Cancer Institute, National Institute of Environmental Health Sciences
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon